APRICOT: Anaesthesia PRactice In Children Observational Trial

NCT ID: NCT01878760

Last Updated: 2015-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aims of the APRICOT study are:

* To establish the incidence of severe critical events in children undergoing anesthesia in Europe.
* To describe the differences in paediatric anaesthesia practice throughout Europe.
* To study the potential impact of this variability on the occurrence of severe critical events (Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Despite the introduction of better-structured programmes for paediatric anaesthesia training and the development of some recommendations for paediatric anaesthesia services, the incidence of severe critical events in children is still unknown in Europe. Considering that the major life-threatening complications following general or regional anaesthesia are uncommon, it is therefore crucial to consider a large multinational, multicentre trial in order to establish a realistic statistical estimation and identify the risk factors for severe critical events. Thus, this prospective observational multicentre cohort study is designed to identify the incidence and potential risk factors of severe critical events in children undergoing anaesthesia in Europe.

The study aims to include all children from birth to 15 years old scheduled for an elective or urgent diagnostic or surgical procedure under sedation or general anaesthesia with or without regional analgesia or under regional anaesthesia. This represents the denominator dataset for calculation of the incidence of severe critical events, which is the primary aim of the study. The anaesthesiologist in charge will record the occurrence of selected severe critical events during and up to 60 minutes after anaesthesia or sedation AND requiring immediate intervention. These severe critical incidents include: Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor. The secondary endpoint is represented by the risk factors and the consequences for the occurrence of these severe critical events including in-hospital mortality established up to 30 days or at discharge. Relevant aspects of the child's medical and family history will be recorded.

Following sample size estimation, we plan to recruit at least 25 000 children over a period of two consecutive weeks including weekends and after-hours across the 30 European countries represented at the European Society of Anaesthesiology Council or part of geographical Europe. The 2-week recruitment period will be chosen by each site commencing on 15 March 2014.The last possible inclusion date will be decided by the Study Steering Committee depending on the recruitment rate. Participating hospitals will be provided with data acquisition sheets that enable anonymous standardized recording of all patients' parameters, which will be used by the local institution to fill in the electronic case report form (eCRF).

Descriptive statistical analysis will be performed for the primary endpoint (occurrence of severe critical events and 95% confidence interval). Univariate and multivariate analysis will be performed to test factors associated with the endpoint. Results of logistic regression will be reported as adjusted odds ratio (OR) with 95 % confidence intervals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anaesthesia Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: from birth to 15 years included
* All children admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or under regional anaesthesia alone. This includes all kind of surgeries and procedures requiring anaesthesia and analgesia to be performed such as central venous access, burn care, cast, etc.,
* Children admitted for a diagnostic procedure under sedation (performed by an Anaesthetist) or general anaesthesia (such as endoscopy, radiology (CT-scan, MRI), cardiac catheterisation and electrophysiology, PET-scan, radiotherapy, lumbar and bone marrow puncture, biopsies), diagnostic procedure under general anaesthesia (such as endoscopy, radiology…)
* Children admitted for urgent or emergency procedure performed in- or out-of-hours.

Exclusion Criteria

* Children admitted directly from the intensive care units to the operating rooms
* Anaesthesia procedures in the neonatal or paediatric intensive care units.
* Age: All children aged ≥ 16 years.
Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Society of Anaesthesiology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Walid Habre, M.D.

Role: STUDY_CHAIR

University Hospital, Geneva

Francis Veyckemans, M.D.

Role: STUDY_DIRECTOR

Cliniques Universitaires St Luc asbl Brussels

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University Graz

Graz, , Austria

Site Status

Cliniques Universitaires St Luc

Brussels, , Belgium

Site Status

General Hospital Pula

Pula, , Croatia

Site Status

University Children´s Hospital

Brno, , Czechia

Site Status

Odense University Hospital

Odense, , Denmark

Site Status

Tartu University Hospital

Tartu, , Estonia

Site Status

Oulu University Hospital

Oulu, , Finland

Site Status

Turku University Hospital

Turku, , Finland

Site Status

CHU Lille

Lille, , France

Site Status

Lapeyronie University Hospital

Montpellier, , France

Site Status

Universitaetsklinikum Leipzig

Leipzig, , Germany

Site Status

Cnopf'sche Kinderklinik/Klinik Hallerwiese

Nuremberg, , Germany

Site Status

Asklepios Klinik Sankt Augustin GmbH - Department of Paediatric Anaesthesia

Sankt Augustin, , Germany

Site Status

Gibraltar Health Authority, St. Bernard´s Hospital

Gibraltar, , Gibraltar

Site Status

Children Hospital P&A Kyriakoy

Athens, , Greece

Site Status

Our Ladys Children's Hospital

Dublin, , Ireland

Site Status

Schneider Children's Medical center of Israel

Petah Tikva, , Israel

Site Status

Instituto Giannina Gaslini

Genoa, , Italy

Site Status

University Clinical Center of Kosovo

Pristina, , Kosovo

Site Status

Children University Hospital

Riga, , Latvia

Site Status

Vilnius Children Hospital

Vilnius, , Lithuania

Site Status

Mater Dei Hospital MSD

Msida, , Malta

Site Status

Maastricht University Medical Center MUMC

Maastricht, , Netherlands

Site Status

Oslo University Hospital, Rikshospitalet

Oslo, , Norway

Site Status

Clinical University Hospital Department of Anaesthesiology and Intensive Care

Wroclaw, , Poland

Site Status

Centro Hospitalar Lisboa Norte - Hospital de Santa Maria

Lisbon, , Portugal

Site Status

Spitalul de Copiin Maria Curie

Bucharest, , Romania

Site Status

Pirogov Russian National Research Medical University

Moscow, , Russia

Site Status

University Childrens hospital

Belgrade, , Serbia

Site Status

Paediatric District Hospital

Banská Bystrica, , Slovakia

Site Status

University Klinical Centre Ljubljana

Ljubljana, , Slovenia

Site Status

Hospital Sant Joan Déu

Esplugues de Llobregat, , Spain

Site Status

Queen Silvis Childrens Hospital Sahlgrens University Hospital

Gothenburg, , Sweden

Site Status

Geneva University Hospitals

Geneva, , Switzerland

Site Status

Anästhesie Kinderspital Klinik für Anästhesie, Intensivmedizin, Rettungsmedizin und Schmerztherapie (KLIFAIRS) Luzerner Kantonsspital Spitalstrasse

Lucerne, , Switzerland

Site Status

Cukurova University Faculty Of Medicine

Adana, , Turkey (Türkiye)

Site Status

P.L.Shupyk National Medical Academy of Postgraduate Education, Municipal Children's Hospital #1

Kyiv, , Ukraine

Site Status

Royal Hospital For Sick Children

Glasgow, Scotland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Belgium Croatia Czechia Denmark Estonia Finland France Germany Gibraltar Greece Ireland Israel Italy Kosovo Latvia Lithuania Malta Netherlands Norway Poland Portugal Romania Russia Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey (Türkiye) Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Dagher K, Benvenuti C, Virag K, Habre W. The Incidence of Postoperative Complications Following Lumbar and Bone Marrow Punctures in Pediatric Anesthesia: Insights From APRICOT. J Pediatr Hematol Oncol. 2024 Apr 1;46(3):165-171. doi: 10.1097/MPH.0000000000002849. Epub 2024 Mar 4.

Reference Type DERIVED
PMID: 38447107 (View on PubMed)

Dahmani S, Laffargue A, Dadure C, Veyckemans F; French APRICOT trial group. Description of practices and complications in the French centres that participated to APRICOT: A secondary analysis. Anaesth Crit Care Pain Med. 2019 Dec;38(6):637-645. doi: 10.1016/j.accpm.2019.06.001. Epub 2019 Jun 11.

Reference Type DERIVED
PMID: 31200009 (View on PubMed)

Virag K, Sabourdin N, Thomas M, Veyckemans F, Habre W; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Epidemiology and incidence of severe respiratory critical events in ear, nose and throat surgery in children in Europe: A prospective multicentre observational study. Eur J Anaesthesiol. 2019 Mar;36(3):185-193. doi: 10.1097/EJA.0000000000000951.

Reference Type DERIVED
PMID: 30640246 (View on PubMed)

Engelhardt T, Virag K, Veyckemans F, Habre W; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Airway management in paediatric anaesthesia in Europe-insights from APRICOT (Anaesthesia Practice In Children Observational Trial): a prospective multicentre observational study in 261 hospitals in Europe. Br J Anaesth. 2018 Jul;121(1):66-75. doi: 10.1016/j.bja.2018.04.013. Epub 2018 May 18.

Reference Type DERIVED
PMID: 29935596 (View on PubMed)

Habre W, Disma N, Virag K, Becke K, Hansen TG, Johr M, Leva B, Morton NS, Vermeulen PM, Zielinska M, Boda K, Veyckemans F; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017 May;5(5):412-425. doi: 10.1016/S2213-2600(17)30116-9. Epub 2017 Mar 28.

Reference Type DERIVED
PMID: 28363725 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APRICOT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Propofol in Emergence Agitation
NCT00535613 COMPLETED PHASE4